← Back to headlines
Raymond James Lowers Viking Therapeutics Price Target
Raymond James has lowered its price target for Viking Therapeutics, Inc. (VKTX), despite an optimistic outlook on the company's clinical initiatives.
4 Mar, 06:45 — 4 Mar, 06:45
Sources
Showing 1 of 1 sources
Related Stories
VW Supervisory Board Unanimously Approves Savings and Restructuring Plan
9m ago
Revolut Secures Conditional Approval for US National Bank Charter
27m ago
Microsoft Introduces Monthly Hour Limits for Xbox Cloud Gaming
57m ago
Ryanair Cuts Winter Flight Capacity and Warns of Fare Increases Amid High Fuel Costs
1h ago